1. Home
  2. SDGR vs CERT Comparison

SDGR vs CERT Comparison

Compare SDGR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$12.15

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$4.59

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDGR
CERT
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
925.8M
860.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
SDGR
CERT
Price
$12.15
$4.59
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$21.00
$11.67
AVG Volume (30 Days)
1.3M
2.9M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
45.14
87.50
EPS
N/A
N/A
Revenue
$255,869,000.00
$418,838,000.00
Revenue This Year
$0.76
$4.18
Revenue Next Year
$4.60
$5.39
P/E Ratio
N/A
N/A
Revenue Growth
23.29
8.75
52 Week Low
$10.95
$4.45
52 Week High
$27.63
$13.88

Technical Indicators

Market Signals
Indicator
SDGR
CERT
Relative Strength Index (RSI) 47.21 26.03
Support Level $11.18 N/A
Resistance Level $13.36 $6.47
Average True Range (ATR) 0.65 0.34
MACD -0.06 -0.18
Stochastic Oscillator 32.53 6.23

Price Performance

Historical Comparison
SDGR
CERT

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: